Status of somatostatin receptor messenger RNAs and binding sites in rat brain during kindling epileptogenesis

Neuroscience

Volumn 75, Issue 3, 1996, Pages 857-868

  Piwko, C ^a   Thoss, V S ^a   Samanin, R ^b   Hoyer, D ^a   Vezzani, A ^b  

^a Preclinical Research   (Switzerland)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

autoradiography; epilepsy; in situ histochemistry; kindled seizure; somatostatin (SRIF, somatotropin release inhibiting factor); sst SRIF receptors

Indexed keywords

MESSENGER RNA; RECEPTOR SUBTYPE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; EPILEPSY; HIPPOCAMPUS; IN SITU HYBRIDIZATION; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SEIZURE;

EID: 0030561398     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00304-1     Document Type: Article

References (60)

1. 1. Beal M. F., Bird E. D., Langlais P. J. and Martin J. B. (1984) Somatostatin is increased in the nucleus accumbens in Huntington's disease. Neurology 34, 663-666.
2. 2. Beal M. F., Mazurek M. F., Black P. McL. and Martin J. B. (1985) Human cerebrospinal fluid somatostatin in neurological disease. J. neurol. Sci. 71, 91-104.
3. 3. Bendotti C., Vezzani A., Tarrizo G. and Samanin R. (1993) Increased expression of GAP-43, somatostatin and neuropeptide Y mRNA in the hippocampus during development of hippocampal kindling in rats. Eur. J. Neurosci. 5, 1312-1320.
4. 4. Buscail L., Esteve J. P., Prats H., Bayard F., Bell G. I., Vaysse N. and Susini C. (1993) Human somatostatin receptor hSSTR-2 may mediate the antiproliferative effect of octreotide. Gastroenterology 104, 816-819.
5. 5. Davies P., Katzman R. and Terry R. D. (1980) Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288, 279-280.
6. 6. deLanerolle N. C., Kim J. K., Robbins R. J. and Spencer D. D. (1989) Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 495, 387-395.
7. 7. Dodd J. and Kelly J. S. (1978) Is somatostatin an excitatory transmitter in the hippocampus? Nature 273, 674-675.
8. 8. Epelbaum J., Dournaud P., Fodor M. and Viollet C. (1994) The neurobiology of somatostatin. Crit. Rev. Neurobiol. 8, 25-44.
9. 9. Epelbaum J., Ruberg M., Moyse E., Javoy-Agid B., Dubois B. and Agid Y. (1983) Somatostatin and dementia in Parkinson's disease. Brain Res. 278, 376-379.
10. 10. Feniuk W., Dimech J. and Humphrey P. P. A. (1993) Characterization of somatostatin receptors in guinea-pig isolated ileum, vas deferens and right atrium. Br. J. Pharmac. 110, 154-157.
11. 11. Ferrier I. N., Roberts G. W., Crow T. J., Johnstone E. C., Owens D. G., Lee Y. C., O'Shaughnessy D., Adrian T. E., Polak J. M. and Bloom S. R. (1983) Reduced cholecystokinin-like immunoreactivity and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia. Life Sci. 33, 475-482.
12. 12. Goddard G. B., McIntyre D. C. and Leech C. K. (1969) A permanent change in brain function resulting from daily electrical stimulation. Expl Neurol. 25, 295-330.
13. 13. Higuchi T., Kokubu T., Sikand G. S., Wada J. A. and Friesen H. G. (1984) A study of somatostatin receptors in amygdaloid-kindled rat brain. J. Neurochem. 43, 1271-1276.
14. 14. Higuchi T., Shah K. R., Sikand G. S., West M. and Friesen H. G. (1984) Changes in immunoreactive somatostatin in brain following lidocaine-induced kindling in rat. Neuropharmacology 23, 1311-1314.
15. 15. Hoyer D., Bell G. I., Berelowitz M., Epelbaum J., Feniuk W., Humphrey P. P. A., O'Carroll A. M., Patel Y. C., Schonbrunn A., Taylor J. E. and Reisine T. (1995) Classification and nomenclature of somatostatin receptors. Trends pharmac. Sci. 16, 86-88.
16. 16. Hoyer D., Lübbert H. and Bruns C. (1994) Molecular pharmacology of somatostatin receptors. Naunyn-Schmiedeberg's Arch. Pharmac. 350, 441-453.
17. 17. Hoyer D., Pérez J., Schoeffter P., Langenegger D., Schupbach E., Kaupmann K., Lubbert H., Bruns C. and Reubi J. C. (1995) Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptors. Eur. J. Pharmac., molec. Pharmac. Sect. 289, 151-161.
18. 18. Kaupmann K., Bruns C., Hoyer D., Seuwen K. and Lübbert H. (1993) Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain. Fedn Eur. biochem. Socs Lett. 331, 53-59.
19. 19. Koch B. D., Dorflinger L. J. and Schonbrunn A. (1985) Pertussis toxin blocks both cyclic AMP-mediated and cyclic AMP-independent action of somatostatin. J. biol. Chem. 260, 13138-13145.
20. 20. Kragh J., Tonder N., Finsen B. R., Zimmer J. and Bolwig T. G. (1994) Repeated electroconvulsive shocks cause transient changes in rat hippocampal somatostatin and neuropeptide Y immunoreactivity and mRNA in situ hybridization signals. Expl Brain Res. 98, 305-313.
21. 21. Mantillas J. R., Siggins G. and Bloom F. E. (1986) Somatostatin selectively enhances acetylcholine-induced excitations in rat hippocampus and cortex. Proc. natn. Acad. Sci. U.S.A. 83, 7518-7521.
22. 22. Manfridi A., Forloni G. L., Vezzani A., Fodritto F. and De Simoni M. G. (1991) Functional and histological consequences of quinolinic and kainic acid-induced seizures on hippocampal somatostatin neurons. Neuroscience 41, 127-135.
23. 23. McNamara J. O. (1994) Cellular and molecular basis of epilepsy. J. Neurosci. 14, 3413-3425.
24. 24. Monno A., Rizzi M., Samanin R. and Vezzani A. (1993) Anti-somatostatin antibody enhances the rate of hippocampal kindling in rats. Brain Res. 602, 148-152.
25. 25. Nemeroff C. B., Youngblood W. W., Manberg P. J., Prange A. J. Jr and Kizer J. S. (1983) Regional brain concentration of neuropeptides in Huntington's chorea and schizophrenia. Science 21, 972-975.
26. 26. Olpe H. R., Balcar V. J., Bittiger H., Rink H. and Sieber P. (1980) Central actions of somatostatin. Eur. J. Pharmac. 63, 127-133.
27. 27. Patel Y. C. and Srikant C. B. (1994) Subtype selectivity of peptide analogues for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology 135, 2814-2817.
28. 28. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
29. 2 and differential changes in somatostatin messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats. Neuroscience 65, 1087-1097.
30. 30. Pittman Q. J. and Siggins G. R. (1981) Somatostatin hyperpolarizes hippocampal pyramidal cells in vitro. Brain Res. 221, 402-408.
31. 2 sites in the rat cerebellum. Naunyn-Schmiedeberg's Arch. Pharmac. 352, 607-613.
32. 32. Piwko C., Thoss V. S. and Hoyer D. (1996) Localization and pharmacological characterization of somatostatin recognition sites in the human cerebellum. Neuropharmacology (in press).
33. 33. Pretel S., Applegate C. D. and Piekut D. T. (1995) Activation of somatostatin-synthesizing neurons in the hippocampal formation through kindling-induced seizures. Hippocampus 5, 40-51.
34. 34. Racine R. (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroenceph. clin. Neurophysiol. 32, 281-294.
35. 35. Raynor K., O'Caroll A. M., Kong H., Yasuda K., Mahan L. C., Bell G. I. and Reisine T. (1993) Characterization of cloned somatostatin receptors. Molec. Pharmac. 44, 385-392.
36. 36. Raynor K., Murphy W. A., Coy D. H., Taylor J. E., Moreau J. P., Yasuda K., Bell G. I. and Reisine T. (1993) Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Molec. Pharmac. 43, 838-844.
37. 37. Reichlin S. (1983) Somatostatin. New Engl. J. Med. 309, 1495-1505, 1556-1563.
38. 38. Reisine T. and Bell G. I. (1995) Molecular properties of somatostatin receptors. Neuroscience 67, 777-790.
39. 39. Reubi J. C. and Maurer R. (1986) Different ionic requirements for somatostatin receptor subpopulation in the brain. Regul. Pept. 14, 301-311.
40. 40. Riekkinen P. J. and Pitkänen A. (1990) Somatostatin and epilepsy. Metabolism 39, 112-115.
41. 41. Rizzi M., Monno A., Samanin R., Sperk G. and Vezzani A. (1993) Electrical kindling of the hippocampus is associated with functional activation of neuropeptide Y-containing neurons. Eur. J. Neurosci. 5, 1534-1538.
42. 42. Robbins R. J., Brines M. L., Kim J. H., Adrian T., Lanerolle N., Welsh S. and Spencer D. D. (1991) A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy. Ann. Neurol. 29, 325-332.
43. 43. Rubinow D. R., Gold P. W., Post R. M. and Ballenger J. C. (1983) CSF somatostatin in affective illness. Archs gen. Psychiat. 40, 409-412.
44. 44. Scharfman H. E. (1993) Presynaptic and postsynaptic actions of somatostatin in area CA1 and the dentate gyrus of rat and rabbit hippocampal slices. In Presynaptic Receptors in the Mammalian Brain (eds Dunwiddie T. V. and Lovinger D. M.), pp. 42-70. Birkhauser, Boston.
45. 45. Schoeffter P., Perez J., Langenegger D., Schüpbach E., Bobirnac I., Lübbert H., Bruns C. and Hoyer D. (1995) Characterization and distribution of somatostatin SS-1 and SRIF-1 binding sites in rat brain: identity with SSTR-2 receptors. Eur. J. Pharmac., molec. Pharmac. Sect. 289, 163-173.
46. 46. Schwarzer C., Sperk G., Samanin R., Rizzi M., Gariboldi M. and Vezzani A. (1996) Lasting changes in neuropeptides mRNA expression and immunoreactivity in kindling: functional implications for limbic epileptogenesis. Brain Res. Rev. 22, 27-50.
47. 47. Schwarzer C., Williamson J. M., Lothman E. W., Vezzani A. and Sperk G. (1995) Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience 69, 831-845.
48. 48. Shin C., Pedersen H. B. and McNamara J. O. (1985) γ-Aminobutyric acid and benzodiazepine receptors in the kindling model of epilepsy: a quantitative radiohistochemical study. J. Neurosci. 5, 2696-2701.
49. 49. Shinoda H., Nadi N. S. and Schwartz J. P. (1991) Alterations in somatostatin and proenkephalin mRNA in response to a single amygdaloid stimulation versus kindling. Molec. Brain Res. 11, 221-226.
50. 50. Sloviter R. S. (1991) Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: the "dormant basket cell" hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus 1, 41-66.
51. 51. Sorensen K. V., Christensen S. E., Dupont E., Hansen P., Pedersen E. and Orskov H. (1980) Low somatostatin content in cerebrospinal fluid in multiple sclerosis. Acta neurol. 61, 186-191.
52. 52. Sperk G., Marksteiner J., Gruber B., Bellmann R., Mahata M. and Ortler M. (1992) Functional changes in neuropeptide Y-and somatostatin-containing neurons induced by limbic seizures in the rat. Neuroscience 50, 831-846.
53. 53. Thoss V. S., Due D. and Hoyer D. (1996) Somatostatin receptors in the developing rat brain. Eur. J. Pharmac. 63, 127-133.
54. 54. Thoss V. S., Pérez J., Duc D. and Hoyer D. (1995) Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain. Neuropharmacology 34, 1673-1688.
55. 55. Thoss V. S., Piwko C. and Hoyer D. (1996) Somatostatin receptors in the Rhesus monkey brain: localization and pharmacological characterization. Naunyn-Schmiedeberg's Arch. Pharmac. 353, 648-660.
56. 56. Tonder N., Kragh J., Finsen B. R., Bolwig T. G. and Zimmer J. (1994) Kindling induces transient changes in neuronal expression of somatostatin, neuropeptide Y, and calbindin in adult rat hippocampus and fascia dentata. Epilepsia 5, 1299-1308.
57. 57. Vezzani A., Monno A., Rizzi M., Galli A., Barrios M. and Samanin R. (1992) Somatostatin release is enhanced in the hippocampus of partially and fully kindled rats. Neuroscience 51, 41-46.
58. 58. Vezzani A., Serafini R., Stasi M. A., Vigano G., Rizzi M. and Samanin R. (1991) A peptidase resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differentially in the rat hippocampus. Neuropharmacology 30, 345-352.
59. 59. Wanscher B., Kragh J., Barry D. I., Bolwig T. and Zimmer J. (1990) Increased somatostatin and enkephalin-like immunoreactivity in the rat hippocampus following hippocampal kindling. Neurosci. Lett. 118, 33-36.
60. 60. Watson T. W. and Pittman Q. J. (1988) Somatostatin(14) and -(28) but not somatostatin(1-12) hyperpolarize CA1 pyramidal neurons in vitro. Brain Res. 448, 40-45.